enGene Holdings Inc. (ENGN)
ENGN moved a median of -0.28% 30 minutes after news, and -0.56% by the close. How ENGN actually reacts to news — the realized, point-in-time move the market made, measured across 333 labeled events over the last three years with zero look-ahead.
ENGN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 42% | 293 |
| 30-min | -0.28% | 44% | 313 |
| 60-min | -0.38% | 42% | 317 |
| to close | -0.56% | 46% | 330 |
| Middle 50% of ENGN reactions | -2.40% to +1.42% |
|---|---|
| Median reaction (30-min) | -0.28% |
| Measured reactions | 333 |
Half of all enGene Holdings Inc. news events land between -2.40% and +1.42% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How ENGN reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 30 | -3.51% | 20% | -12.28% |
| Coverage initiations | 35 | -3.03% | 29% | -4.45% |
| Rating reiterations | 45 | -0.79% | 44% | -1.81% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how ENGN ranks against every other measured name →
That’s how ENGN usually reacts — get an email when it moves on news →Email me when ENGN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ENGN's baseline. Nothing else.
Recent ENGN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| enGene to Host KOL Webinar on October 15, 2026 | Press release | Business Wire | -0.71% | -3.55% | |
| enGene Reports Third Quarter 2026 Financial Results and Provides Business Update | Press release | Business Wire | -1.65% | +5.50% | |
| Form 10-Q enGene Therapeutics Inc. For: Jul 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.65% | +5.50% | |
| Form 8-K enGene Therapeutics Inc. For: Sep 08 | SEC filing · Form 8-K | SEC EDGAR | -1.65% | +5.50% | |
| enGene to Participate in Upcoming Investor Conferences | Press release | Business Wire | -0.54% | +0.81% | |
| Form 8-K enGene Therapeutics Inc. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -1.64% | -7.10% | |
| enGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 | Press release | Business Wire | +0.59% | +0.56% | |
| Form 8-K enGene Therapeutics Inc. For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | +0.87% | +2.19% | |
| enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones | Press release | Business Wire | -0.21% | +1.59% | |
| Form 8-K enGene Therapeutics Inc. For: Jul 15 | SEC filing · Form 8-K | SEC EDGAR | -0.21% | +1.59% | |
| Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman | Press release | GlobeNewswire | +0.32% | +1.06% | |
| Form 8-K/A enGene Therapeutics Inc. For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | +0.17% | -2.87% | |
| enGene Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | Business Wire | +3.71% | +1.14% | |
| Form 10-Q enGene Therapeutics Inc. For: Apr 30 | SEC filing · Form 10-Q | SEC EDGAR | +3.71% | +1.14% | |
| Form 8-K enGene Therapeutics Inc. For: Jun 13 | SEC filing · Form 8-K | SEC EDGAR | +3.71% | +1.14% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages enGene Therapeutics Inc. (ENGN) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | -2.41% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating enGene Therapeutics Inc. (ENGN) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.00% | +1.86% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against enGene Therapeutics Inc. (ENGN) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.62% | -0.93% | |
| Form 8-K enGene Therapeutics Inc. For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | -1.55% | +1.86% | |
| enGene Therapeutics Inc. (ENGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | -1.49% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages enGene Therapeutics Inc. (ENGN) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.30% | -0.30% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against enGene Therapeutics Inc. (ENGN) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.30% | -0.89% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages enGene Therapeutics Inc. (ENGN) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.29% | +0.29% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against enGene Therapeutics Inc. (ENGN) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | -0.81% | -3.26% | |
| Form ARS enGene Therapeutics Inc. For: Oct 31 | SEC filing · Form ARS | SEC EDGAR | -1.99% | -1.32% | |
| Form DEF 14A enGene Therapeutics Inc. For: Jun 09 | SEC filing · Form DEF | SEC EDGAR | -1.99% | -1.32% | |
| enGene Announces Updated Interim Results From LEGEND Pivotal Cohort | Press release | Business Wire | -5.37% | -19.63% | |
| Form 8-K enGene Therapeutics Inc. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -5.37% | -19.63% | |
| enGene Announces Name Change to enGene Therapeutics Inc. | Press release | Business Wire | +2.23% | +1.95% | |
| Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care | Press release | PR Newswire | -0.64% | +2.49% | |
| enGene Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | Business Wire | -1.49% | -12.53% | |
| Form 10-Q enGene Holdings Inc. For: Jan 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.49% | -12.53% | |
| Form 8-K enGene Holdings Inc. For: Mar 09 | SEC filing · Form 8-K | SEC EDGAR | -1.49% | -12.53% | |
| Form S-8 enGene Holdings Inc. | SEC filing · Form S-8 | SEC EDGAR | -3.08% | -11.38% | |
| Form EFFECT enGene Holdings Inc. | SEC filing · Form EFFECT | SEC EDGAR | -0.86% | -1.93% | |
| enGene to Participate in Upcoming Investor Conferences | Press release | Business Wire | -2.40% | -0.67% | |
| Form 10-K/A enGene Holdings Inc. For: Oct 31 | SEC filing · Form 10-K | SEC EDGAR | -2.40% | -0.67% | |
| Form S-3 enGene Holdings Inc. | SEC filing · Form S-3 | SEC EDGAR | -2.40% | -0.67% | |
| enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 | Press release | Business Wire | -0.30% | -4.10% | |
| Form 8-K enGene Holdings Inc. For: Jan 20 | SEC filing · Form 8-K | SEC EDGAR | -0.44% | +2.64% | |
| enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. | Press release | Business Wire | -0.44% | +2.64% | |
| enGene Reports Full Year 2025 Financial Results and Provides Business Update | Press release | Business Wire | +3.31% | +5.13% | |
| Form 10-K enGene Holdings Inc. For: Oct 31 | SEC filing · Form 10-K | SEC EDGAR | +3.31% | +5.13% | |
| Form 8-K enGene Holdings Inc. For: Dec 22 | SEC filing · Form 8-K | SEC EDGAR | +3.31% | +5.13% | |
| enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness | Press release | Business Wire | +1.13% | -1.50% | |
| enGene to Present at the Piper Sandler 37th Annual Healthcare Conference | Press release | Business Wire | +1.63% | +4.75% | |
| Form 8-K enGene Holdings Inc. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | -1.23% | -5.51% | |
| enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants | Press release | Business Wire | -1.30% | — | |
| enGene Announces Proposed Public Offering of Common Shares | Press release | Business Wire | -1.30% | — | |
| Form 8-K enGene Holdings Inc. For: Nov 11 | SEC filing · Form 8-K | SEC EDGAR | -3.71% | -10.61% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ENGN section they belong to.
Where else ENGN is measured.
ENGN earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is enGene Holdings Inc.'s median reaction calculated?
Every labeled ENGN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 333 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of ENGN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ENGN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.